Literature DB >> 19451795

Efavirenz and bone health.

Gianluigi Fabbriciani, Giuseppe Vittorio L De Socio.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19451795     DOI： 10.1097/QAD.0b013e32832bab0f

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

1.  Antiretroviral therapy and adverse skeletal effects.

Authors:  Gianluigi Fabbriciani; Giuseppe V L De Socio; Marco Massarotti
Journal:  Mayo Clin Proc       Date:  2011-09       Impact factor: 7.616

2.  Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.

Authors:  Grace A McComsey; Douglas Kitch; Eric S Daar; Camlin Tierney; Nasreen C Jahed; Pablo Tebas; Laurie Myers; Kathleen Melbourne; Belinda Ha; Paul E Sax
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

Review 3.  Bone disease in HIV infection: a practical review and recommendations for HIV care providers.

Authors:  Grace A McComsey; Pablo Tebas; Elizabeth Shane; Michael T Yin; E Turner Overton; Jeannie S Huang; Grace M Aldrovandi; Sandra W Cardoso; Jorge L Santana; Todd T Brown
Journal:  Clin Infect Dis       Date:  2010-10-15       Impact factor: 9.079

4.  Hyperparathyroidism and complications associated with vitamin D deficiency in HIV-infected adults in New York City, New York.

Authors:  Candice K Kwan; Benjamin Eckhardt; Jonathan Baghdadi; Judith A Aberg
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-23       Impact factor: 2.205

5.  The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations.

Authors:  Edgar Turner Overton; Michael T Yin
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

6.  Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States.

Authors:  Oluwatoyin M Adeyemi; Denis Agniel; Audrey L French; Phyllis C Tien; Kathleen Weber; Marshall J Glesby; Maria C Villacres; Anjali Sharma; Daniel Merenstein; Elizabeth T Golub; William Meyer; Mardge Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

7.  Impact of age on markers of HIV-1 disease.

Authors:  Vanessa Pirrone; David J Libon; Christian Sell; Chad A Lerner; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

8.  Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen.

Authors:  Anali Conesa-Botella; Eric Florence; Lutgarde Lynen; Robert Colebunders; Joris Menten; Rodrigo Moreno-Reyes
Journal:  AIDS Res Ther       Date:  2010-11-23       Impact factor: 2.250

9.  Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.

Authors:  Ozlem Altuntas Aydın; Hayat Kumbasar Karaosmanoglu; Rıdvan Karahasanoglu; Meryem Tahmaz; Ozcan Nazlıcan
Journal:  Braz J Infect Dis       Date:  2013-09-25       Impact factor: 3.257
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.